 The article discusses the measles vector platform technology derived from the safe and highly efficacious measles virus vaccine, which is under evaluation as a promising plug-and-play vaccine platform technology for rapid development of affected, prevented vaccines against viral and other infectious diseases. This article was authored by Christian Goerke, FanRamphie in France, Katrin Ramsauer, and others.